| Organism name | Chamaecyparis formosensis |
|---|---|
| Genus | Chamaecyparis |
| Family | Cupressaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Chamaecyparis formosensis |
|---|---|
| Linked NCBI taxonomy ID | 187461 |
| Linked level | species |
| Family in NCBI taxonomy | Cupressaceae |
|---|---|
| ID | 3367 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | Spermatophyta |
|---|---|
| ID | 58024 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00005374
|
Quercetin
|
CHEMBL82242
CHEMBL479232 CHEMBL1437696 |
C012526
|
14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 |
|
|
C00005140
|
Afzelin
/ Kaempferol 3-O-alpha-rhamnoside / Kaempferol 3-O-alpha-L-rhamnopyranoside |
CHEMBL240528
CHEMBL515798 |
C477954
|
4 / 2 / 2 | No. 2 | No. 15 |
|
|
|
C00001015
|
Amentoflavone
|
CHEMBL63354
|
C011164
|
50 / 39 / 29 | 5 / 0 | No. 34 | No. 18 |
|
|
C00001049
|
Hinokiflavone
|
CHEMBL291426
|
C060299
|
2 / 1 / 2 | No. 34 | No. 18 |
|
|
|
C00006487
|
Sequoiaflavone
|
CHEMBL255493
|
1 / 0 / 0 | No. 34 | No. 18 |
|
||
|
C00038189
|
1beta-Hydroxypisiferanol
/ (+)-1beta-Hydroxypisiferanol |
No. 41 | No. 62 |
|
||||
|
C00003672
|
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
|
||
|
C00023774
|
Fucostanol
/ Stigmasterol / Dihydro-beta-sitosterol / (24S)24-Ethylcholestain-3beta-ol |
CHEMBL66943
CHEMBL186373 CHEMBL400247 CHEMBL1568947 |
D013265
|
5 / 0 / 0 | 1 / 0 | No. 53 | No. 11 |
|
|
C00004565
|
Kaempferol
/ Nimbecetin / Rhamnolutein / Pelargidenolon / 5,7,4'-Trihydroxyflavonol / 3,5,7,4'-Tetrahydroxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL150
|
C006552
|
76 / 69 / 87 | 86 / 8 | No. 71 | No. 15 |
|
|
C00036233
|
trans-Communic acid
|
CHEMBL498097
CHEMBL1488779 CHEMBL1731589 |
13 / 14 / 8 | No. 143 |
|
|||
|
C00012750
|
(+)-Costal
/ Costic aldehyde / (+)-beta-Costal / Eudesma-4(14),11(13)-dien-12-al |
CHEMBL362552
|
No. 151 | No. 38 |
|
|||
|
C00012737
|
alpha-Costol
/ (-)-alpha-Costol / [2R-(2alpha,4aalpha,8abeta)]-1,2,3,4,4a,5,6,8a-Octahydro-4a,8-dimethyl-beta-methylene-2-naphthaleneethanol |
No. 151 | No. 38 |
|
||||
|
C00012749
|
(+)-Costol
/ beta-Costol / Sesquibenihiol / (+)-beta-Costol / Eudesma-4(14),11(13)-dien-12-ol / [2R-(2alpha,4aalpha,8abeta)]-Decahydro-4a-methyl-b,8-bis(methylene)-2-naphthaleneethanol |
No. 151 | No. 38 |
|
||||
|
C00007253
|
ent-Kaurene
/ ent-Kaur-16-ene / (-)-ent-Kaur-16-ene |
CHEMBL454740
|
No. 159 | No. 41 |
|
|||
|
C00003112
|
Cedrol
/ (+)-Cedrol / alpha-Cedrol |
CHEMBL1592444
CHEMBL1974890 |
C078669
|
5 / 14 / 11 | No. 161 | No. 38 |
|
|
|
C00040541
|
trans-Communol
|
No. 165 |
|
|||||
|
C00020065
|
alpha-Cadinol
/ (-)-alpha-Cadinol |
CHEMBL486795
|
No. 205 | No. 38 |
|
|||
|
C00031283
|
Sandaracopimaric acid
/ (-)-Sandaracopimaric acid |
CHEMBL513197
CHEMBL1397211 CHEMBL1410398 CHEMBL1735595 |
C082072
|
14 / 13 / 7 | No. 208 | No. 48 |
|
|
|
C00003444
|
miropinic acid
/ Isopimaric acid / isodextropimaric acid |
CHEMBL512164
|
C115138
|
3 / 1 / 1 | No. 208 | No. 48 |
|
|
|
C00007203
|
(+)-Wikstromol
/ (+)-Nortrachelogenin |
CHEMBL453799
CHEMBL1483370 |
3 / 2 / 2 | No. 223 | No. 21 |
|
||
|
C00007201
|
(-)-Pluviatolide
|
CHEMBL63962
|
C016678
|
No. 223 | No. 21 |
|
||
|
C00000599
|
(-)-Wikstromol
/ (-)-Nortrachelogenin |
CHEMBL453799
CHEMBL1483370 |
C020436
|
3 / 2 / 2 | No. 223 | No. 21 |
|
|
|
C00038321
|
7-Hydroxymatairesinol
/ (-)-7-Hydroxymatairesinol |
CHEMBL470875
CHEMBL513565 |
No. 223 | No. 21 |
|
|||
|
C00000721
|
Taiwanin E
|
CHEMBL468453
|
No. 285 | No. 21 |
|
|||
|
C00038725
|
Chaenocephalol
|
CHEMBL487595
CHEMBL503863 CHEMBL526915 CHEMBL461400 CHEMBL461399 CHEMBL1814427 |
No. 311 |
|
||||
|
C00036186
|
O-Methylpisiferic acid
|
CHEMBL479111
|
No. 323 | No. 41 |
|
|||
|
C00003470
|
Pisiferic acid
|
C060710
|
No. 323 | No. 41 |
|
|||
|
C00040407
|
Sugiol methyl ether
/ (+)-Sugiol methyl ether |
CHEMBL376833
CHEMBL376834 |
1 / 2 / 2 | No. 355 |
|
|||
|
C00040508
|
Totarol
/ (+)-Totarol |
CHEMBL487602
CHEMBL1474684 CHEMBL1999971 |
C078548
|
20 / 19 / 47 | No. 359 | No. 40 |
|
|
|
C00040023
|
Pisiferal
/ (+)-Pisiferal |
No. 359 | No. 40 |
|
||||
|
C00040024
|
Pisiferol
|
CHEMBL193987
|
No. 359 | No. 40 |
|
|||
|
C00040276
|
Sempervirol
|
CHEMBL1097038
|
No. 359 | No. 40 |
|
|||
|
C00003426
|
Ferruginol
|
CHEMBL197308
|
No. 359 | No. 40 |
|
|||
|
C00039446
|
Isohinokiol
|
CHEMBL1277661
|
No. 359 | No. 40 |
|
|||
|
C00035987
|
bietatriene
/ Dehydroabietane / Abieta-8,11,13-triene |
No. 359 | No. 40 |
|
||||
|
C00038205
|
20-Acetoxypisiferol
|
No. 359 | No. 40 |
|
||||
|
C00032365
|
Totaradiol
/ 3beta-Hydroxytotarol |
CHEMBL446064
|
No. 359 | No. 40 |
|
|||
|
C00038153
|
12-O-Methylpisiferanol
|
No. 359 | No. 40 |
|
||||
|
C00038152
|
12-O-Methylisohinokiol
|
No. 359 | No. 40 |
|
||||
|
C00038150
|
12-Methylferruginol
/ 12-O-Methylferruginol / (+)-12-Methylferruginol / (+)-12-O-Methylferruginol |
CHEMBL226233
CHEMBL226235 |
1 / 2 / 2 | No. 359 | No. 40 |
|
||
|
C00031045
|
Pisiferanol
/ (+)-Pisiferanol |
No. 359 | No. 40 |
|
||||
|
C00021881
|
Hinokiic acid
/ Widdrenic acid / Thujopsenic acid |
CHEMBL1724720
|
4 / 5 / 3 | No. 365 | No. 38 |
|
||
|
C00040487
|
Thujopsenol
|
No. 365 | No. 38 |
|
||||
|
C00049951
|
4alpha-Hydroxyeudesm-11-en-12-al
|
CHEMBL187634
CHEMBL594843 |
No. 398 | No. 38 |
|
|||
|
C00011040
|
trans-(-)-Pinocarveol
|
No. 476 | No. 35 |
|
||||
|
C00000163
|
alpha-Eudesmol
|
C118684
|
No. 524 | No. 38 |
|
|||
|
C00000165
|
gamma-Eudesmol
|
CHEMBL477900
|
No. 613 | No. 38 |
|
|||
|
C00002608
|
Hinokinin
/ Hinoquinin / (-)-Hinokinin / (-)-Hinoquinin |
CHEMBL180970
CHEMBL182073 CHEMBL242011 |
C475934
|
2 / 1 / 1 | No. 629 | No. 21 |
|
|
|
C00003467
|
Phytol
/ trans-Phytol |
CHEMBL390773
CHEMBL1644111 |
D010836
|
0 / 5 | No. 641 | No. 38 |
|
|
|
C00038248
|
3beta-Hydroxy-1-oxo-13-O-methyltotarol
/ (+)-3beta-Hydroxy-1-oxo-13-O-methyltotarol |
No. 760 |
|
|||||
|
C00040509
|
Totarolone
|
No. 760 |
|
|||||
|
C00033539
|
1-Oxo-3beta-Hydroxytotarol
/ 3beta-Hydroxy-1-oxototarol |
No. 760 |
|
|||||
|
C00002609
|
Hinokiol
/ (+)-Hinokiol |
CHEMBL16901
|
26 / 24 / 20 | No. 761 | No. 23 |
|
||
|
C00038786
|
cis-2,4-Dihydroxycinnamic acid
|
CHEMBL1235981
|
No. 904 | No. 6 |
|
|||
|
C00000152
|
p-Coumaric acid
|
CHEMBL66879
CHEMBL2336752 |
C032171
|
23 / 13 / 18 | 6 / 1 | No. 904 | No. 6 |
|
|
C00002683
|
Vanillin
|
CHEMBL13883
|
18 / 8 / 9 | No. 1003 |
|
|||
|
C00002624
|
Savinin
/ (-)-Savinin / (-)-Hibalactone |
CHEMBL395263
CHEMBL459851 |
7 / 10 / 5 | No. 1029 | No. 21 |
|
||
|
C00002503
|
Umbelliferon
/ Umbelliferone / 7-Hydroxycoumarin |
CHEMBL51628
|
C031477
|
39 / 33 / 32 | 9 / 0 | No. 1030 | No. 25 |
|
|
C00002743
|
Ferulic acid
/ 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid |
CHEMBL32749
|
C004999
|
110 / 52 / 40 | 16 / 6 | No. 1366 | No. 6 |
|
|
C00020240
|
Oplopanone
/ (-)-Oplopanone |
No. 1395 |
|
|||||
|
C00038188
|
1beta-Hydroxyisopisiferin
/ (-)-1??-Hydroxyisopisiferin |
No. 1406 |
|
|||||
|
C00031046
|
Pisiferin
|
No. 1406 |
|
|||||
|
C00003147
|
Humulene
/ alpha-Caryophyllene / (+/-)-alpha-Humulene |
CHEMBL251280
|
C042686
|
No. 1421 | No. 38 |
|
||
|
C00012804
|
Eudesm-4(15)-en-5-ol
/ [3R-(3alpha,4abeta,8aalpha)]-Octahydro-8a-methyl-5-methylene-3-(1-methylethyl)-4a(2H)-naphthalenol |
No. 1544 |
|
|||||
|
C00002645
|
p-Cresol
/ 4-Methylphenol |
CHEMBL16645
|
C032538
|
8 / 4 / 4 | 10 / 4 | No. 1546 |
|
|
|
C00031014
|
4-Hydroxycinnamaldehyde
/ p-Hydroxycinnamaldehyde |
CHEMBL431836
CHEMBL1956164 |
3 / 4 / 3 | No. 1979 | No. 6 |
|
||
|
C00002657
|
p-Formylphenol
/ 4-Hydroxybenzaldehyde / p-Hydroxybenzaldehyde |
CHEMBL14193
|
C011483
|
3 / 2 / 2 | No. 2076 |
|
||
|
C00007630
|
beta-Sesquiphellandrene
|
CHEMBL469718
|
No. 2380 | No. 38 |
|
|||
|
C00013214
|
(+)-Chamecynenol
/ (1alpha,4aalpha,7alpha,8aalpha)-(+)-7-ethynyl-1,2,4a,5,6,7,8,8a-Octahydro-4a-methyl-1-naphthalenemethanol |
No. 2403 |
|
|||||
|
C00013219
|
7beta-ethynyl-4a,5,6,7,8,8abeta-Hexahydro-1alpha-hydroxy-1,4ab-dimethyl-2(1H)-naphthalenone
|
No. 2403 |
|
|||||
|
C00013217
|
Chamecynone
/ Chamaecynone / [1S-(1alpha,4abeta,7beta,8abeta)]-7-Ethynyl-4a,5,6,7,8,8a-hexahydro-1,4a-dimethyl-2(1H)-naphthalenone |
CHEMBL504738
CHEMBL466987 |
C090327
|
No. 2403 |
|
|||
|
C00013218
|
Isochamaecynone
/ [1R-(1alpha,4aalpha,7alpha,8aalpha)]-7-ethynyl-4a,5,6,7,8,8a-Hexahydro-1,4a-dimethyl-2(1H)-naphthalenone |
CHEMBL504738
CHEMBL466987 |
No. 2403 |
|
||||
|
C00011032
|
(1R,2S,5R)-(+)-10-Pinanol
|
No. 3438 |
|
|||||
|
C00013216
|
Dehydrochamecynenal
/ (4aalpha,7alpha,8aalpha)-7-Ethynyl-4a,5,6,7,8,8a-Hexahydro-4a-methyl-1-naphthalenecarboxaldehyde |
No. 4409 |
|
|||||
|
C00013215
|
Dehydrochamecynenol
/ (-)-Dehydrochamecynenol / [4aS-(4aalpha,7alpha,8aalpha)]-7-Ethynyl-4a,5,6,7,8,8a-hexahydro-4a-methyl-1-naphthalenemethanol |
No. 4409 |
|
|||||
|
C00038715
|
Cedrusin tetraacetate
|
No. 6158 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q99700 | Ataxin-2 | Unclassified protein | C00000599 C00002503 C00002609 C00002624 C00004565 C00007203 C00040508 | 1 / 1 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00001015 C00002503 C00002683 C00003112 C00004565 C00005374 C00031014 | 0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00001015 C00002609 C00004565 C00005374 C00031283 C00036233 C00040508 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002624 C00002645 C00002683 C00004565 C00031283 C00040508 | 0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002608 C00002743 C00003672 C00004565 C00005140 C00040508 | 0 / 1 |
| O75496 | Geminin | Unclassified protein | C00002503 C00002609 C00002743 C00021881 C00031283 C00040508 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002503 C00002743 C00004565 C00005374 C00031014 C00040508 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001015 C00002609 C00004565 C00031014 C00036233 C00040508 | 4 / 3 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001015 C00002503 C00002609 C00004565 C00005374 C00036233 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002608 C00002743 C00003672 C00004565 C00005140 | 1 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00000152 C00002503 C00002743 C00003672 C00004565 | 4 / 2 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00001015 C00004565 C00005374 C00031283 C00036233 | 1 / 1 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001015 C00002609 C00002624 C00031283 C00040508 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00001015 C00002503 C00002609 C00004565 C00040508 | 2 / 5 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001015 C00002624 C00004565 C00005374 C00036233 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001015 C00002503 C00002609 C00004565 C00040508 | 1 / 2 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001015 C00002503 C00002683 C00005374 C00036233 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000599 C00007203 C00021881 C00031283 C00036233 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000152 C00002503 C00002743 C00004565 | 0 / 3 |
| P22303 | Acetylcholinesterase | Hydrolase | C00002503 C00002645 C00002743 C00004565 | 1 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00000152 C00002743 C00003672 C00004565 | 1 / 1 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002503 C00002743 C00004565 C00005374 | 1 / 1 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001015 C00002503 C00002683 C00004565 | 2 / 2 |
| P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001015 C00002609 C00003444 C00031283 | 1 / 1 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002743 C00003672 C00004565 C00031283 | 1 / 1 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002609 C00004565 C00005374 C00036233 | 0 / 0 |
| P56817 | Beta-secretase 1 | A1A | C00001015 C00001049 C00002503 C00006487 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000599 C00002503 C00002609 C00007203 | 1 / 1 |
| P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001015 C00002609 C00003444 C00031283 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001015 C00005374 C00036233 C00040508 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002503 C00002683 C00003672 C00004565 | 1 / 1 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001015 C00002624 C00031283 C00036233 | 7 / 3 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002743 C00003672 C00004565 C00031283 | 0 / 1 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001015 C00002609 C00031283 C00040508 | 2 / 0 |
| P15121 | Aldose reductase | Enzyme | C00000152 C00002503 C00004565 C00005374 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00002609 C00003672 C00023774 C00036233 | 0 / 0 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00000152 C00002503 C00002743 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001015 C00031283 C00040508 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00002743 C00003112 C00040508 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00000152 C00002503 C00002743 | 1 / 2 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002743 C00003672 C00004565 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000152 C00002743 C00004565 | 1 / 8 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00000152 C00002503 C00002743 | 0 / 1 |
| P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00002683 C00002743 C00023774 | 0 / 0 |
| P10275 | Androgen receptor | NR3C4 | C00002645 C00002683 C00004565 | 3 / 4 |
| P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002609 C00002683 C00004565 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002624 C00031283 C00040508 | 1 / 0 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00000152 C00002503 C00002743 | 1 / 2 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002624 C00021881 C00040508 | 1 / 1 |
| P08183 | Multidrug resistance protein 1 | drug | C00003672 C00004565 | 1 / 0 |
| Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001015 C00036233 | 2 / 1 |
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002503 C00002743 | 3 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00004565 C00040508 | 7 / 37 |
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00002503 C00003672 | 1 / 1 |
| P22748 | Carbonic anhydrase 4 | Lyase | C00000152 C00002743 | 1 / 1 |
| P07451 | Carbonic anhydrase 3 | Lyase | C00000152 C00002743 | 0 / 0 |
| P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00002645 C00002683 | 0 / 0 |
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002503 C00002743 | 5 / 1 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00002503 C00002683 | 0 / 0 |
| P98170 | E3 ubiquitin-protein ligase XIAP | Other cytosolic protein | C00004565 C00005140 | 1 / 1 |
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002609 C00004565 | 0 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00003112 C00004565 | 0 / 0 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002743 C00004565 | 2 / 2 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001015 C00002743 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001015 C00002743 | 0 / 0 |
| P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002657 C00002683 | 1 / 1 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00001015 C00003112 | 3 / 1 |
| Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00002503 C00002683 | 0 / 0 |
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00002645 C00004565 | 0 / 0 |
| Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000152 C00002743 | 3 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002503 C00004565 | 3 / 3 |
| P04062 | Glucosylceramidase | Enzyme | C00002503 C00004565 | 6 / 4 |
| Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000152 C00002743 | 0 / 0 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00002683 C00004565 | 0 / 0 |
| P37840 | Alpha-synuclein | Unclassified protein | C00002609 C00021881 | 4 / 2 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00004565 C00023774 | 0 / 0 |
| P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00002657 C00002683 | 1 / 1 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002743 C00004565 | 0 / 0 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002609 C00004565 | 5 / 3 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001015 C00002743 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002609 C00002743 | 0 / 0 |
| P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000152 C00002743 | 0 / 0 |
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00038150 C00040407 | 2 / 2 |
| P23280 | Carbonic anhydrase 6 | Lyase | C00000152 C00002743 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00002743 C00004565 | 0 / 1 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00004565 C00040508 | 0 / 0 |
| P43235 | Cathepsin K | C1A | C00001015 C00001049 | 1 / 2 |
| P43166 | Carbonic anhydrase 7 | Lyase | C00000152 C00002743 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00002503 C00002743 | 0 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 C00004565 | 0 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001015 C00002743 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001015 C00002743 | 1 / 0 |
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002503 C00002743 | 0 / 0 |
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000152 C00002743 | 0 / 0 |
| O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00002645 C00002683 | 0 / 0 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002609 C00004565 | 0 / 0 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001015 C00002609 | 2 / 2 |
| P02545 | Prelamin-A/C | Unclassified protein | C00003112 C00004565 | 11 / 10 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002503 C00003444 | 0 / 0 |
| Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000152 C00002743 | 0 / 0 |
| P55072 | Transitional endoplasmic reticulum ATPase | Unclassified protein | C00001015 | 2 / 1 |
| P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000152 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002743 | 0 / 0 |
| P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00002657 | 0 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00040508 | 0 / 0 |
| P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00004565 | 1 / 1 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00002743 | 2 / 2 |
| P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00002503 | 1 / 1 |
| P50225 | Sulfotransferase 1A1 | Enzyme | C00002645 | 0 / 0 |
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002743 | 1 / 0 |
| Q9Y2T6 | G-protein coupled receptor 55 | Lysophosphatidylinositol receptor | C00002609 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002743 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
| P18405 | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Oxidoreductase | C00002503 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00002743 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00002743 | 0 / 0 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002743 | 0 / 0 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00004565 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00002743 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002743 | 0 / 0 |
| P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002503 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00002743 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002743 | 0 / 0 |
| P10145 | Interleukin-8 | Secreted protein | C00002645 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002743 | 1 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00002743 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002743 | 1 / 1 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002743 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00002743 | 0 / 0 |
| P27487 | Dipeptidyl peptidase 4 | S9B | C00004565 | 0 / 1 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002743 | 1 / 0 |
| O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00002683 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00002743 | 0 / 0 |
| Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00004565 | 1 / 1 |
| P03956 | Interstitial collagenase | M10A | C00002743 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002743 | 0 / 0 |
| Q9Y3R4 | Sialidase-2 | Enzyme | C00004565 | 0 / 0 |
| P47712 | Cytosolic phospholipase A2 | Enzyme | C00001015 | 0 / 0 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005374 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002503 | 0 / 0 |
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002609 | 0 / 0 |
| P14555 | Phospholipase A2, membrane associated | Enzyme | C00001015 | 0 / 0 |
| P00734 | Prothrombin | S1A | C00003672 | 4 / 2 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002743 | 0 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002743 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002743 | 0 / 0 |
| P34972 | Cannabinoid receptor 2 | Cannabinoid receptor | C00002609 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00002743 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002743 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002743 | 2 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002743 | 0 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00002743 | 2 / 0 |
| P15692 | Vascular endothelial growth factor A | Secreted protein | C00001015 | 1 / 2 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002743 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002743 | 1 / 0 |
| Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004565 | 4 / 4 |
| P16083 | Ribosyldihydronicotinamide dehydrogenase [quinone] | Enzyme | C00005140 | 0 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00002743 | 0 / 0 |
| P06276 | Cholinesterase | Hydrolase | C00004565 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002743 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002743 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002743 | 0 / 0 |
| P06280 | Alpha-galactosidase A | Enzyme | C00002503 | 1 / 1 |
| P04745 | Alpha-amylase 1 | Enzyme | C00004565 | 0 / 0 |
| Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00004565 | 0 / 0 |
| Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00002609 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002743 | 1 / 0 |
| Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00002683 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002743 | 2 / 1 |
| P49763 | Placenta growth factor | Unclassified protein | C00001015 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002743 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002743 | 0 / 0 |
| P08253 | 72 kDa type IV collagenase | M10A | C00001015 | 1 / 3 |
| P07237 | Protein disulfide-isomerase | Enzyme | C00005374 | 0 / 0 |
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004565 | 2 / 0 |
| Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000152 | 0 / 0 |
| Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00004565 | 0 / 0 |
| Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00004565 | 0 / 0 |
| P78527 | DNA-dependent protein kinase catalytic subunit | Atypical serine/threonine protein kinase PIKK subfamily | C00002683 | 0 / 0 |
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00002503 | 0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002743 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00002743 | 0 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002743 | 1 / 0 |
| P09884 | DNA polymerase alpha catalytic subunit | Transferase | C00023774 | 0 / 0 |
| P08246 | Neutrophil elastase | S1A | C00002743 | 2 / 1 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002743 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002743 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00002743 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002743 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00002743 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00002743 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002743 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002743 | 0 / 0 |
| P19174 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Enzyme | C00001015 | 0 / 0 |
| O15496 | Group 10 secretory phospholipase A2 | Enzyme | C00001015 | 0 / 0 |
| P55210 | Caspase-7 | C14 | C00002503 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002743 | 0 / 0 |
| P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00004565 | 0 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002743 | 1 / 1 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002743 | 0 / 0 |
| P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004565 | 0 / 0 |
| O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00000152 | 0 / 0 |
| P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000152 | 1 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 |
| P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00004565 | 0 / 0 |
| Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00004565 | 1 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00036233 | 0 / 0 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 1 |
| Q9NPH5 | NADPH oxidase 4 | Enzyme | C00004565 | 0 / 0 |
| P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000152 | 1 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002743 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00002743 | 0 / 0 |
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00004565 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002743 | 1 / 1 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00002743 | 0 / 1 |
| Q04760 | Lactoylglutathione lyase | Enzyme | C00004565 | 0 / 0 |
| P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00004565 | 0 / 0 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002743 | 0 / 0 |
| P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00040508 | 0 / 0 |
| P48147 | Prolyl endopeptidase | S9A | C00004565 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002743 | 0 / 0 |
| Q12794 | Hyaluronidase-1 | Enzyme | C00002743 | 1 / 2 |
| Q9GZV3 | High affinity choline transporter 1 | Choline Na-symporter | C00002609 | 1 / 0 |
| Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | C00001015 | 0 / 0 |
| Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002743 | 1 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00004565 | 0 / 0 |
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00002743 | 0 / 0 |
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00004565 | 0 / 0 |
| Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001015 | 0 / 0 |
| P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001015 | 1 / 0 |
| P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001015 | 0 / 0 |
| O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001015 | 1 / 1 |
| P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001015 | 0 / 0 |
| Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001015 | 0 / 0 |
| P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001015 | 0 / 0 |
| Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001015 | 0 / 0 |
| P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001015 | 0 / 0 |
| O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001015 | 0 / 0 |
| P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001015 | 4 / 2 |
| P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001015 | 0 / 0 |
| Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001015 | 0 / 0 |
| P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001015 | 1 / 0 |
| O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00004565 | 0 / 0 |
| P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00004565 | 0 / 0 |
| P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00004565 | 0 / 0 |
| Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00004565 | 0 / 0 |
| Q02880 | DNA topoisomerase 2-beta | Isomerase | C00023774 | 0 / 0 |
| P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00004565 | 0 / 0 |
| P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00004565 | 0 / 0 |
| Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00004565 | 0 / 0 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00002743 | 0 / 0 |
| Q00796 | Sorbitol dehydrogenase | Enzyme | C00002503 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000152
C00002743
C00004565
C00005374
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000152
C00001015
C00002743
C00004565
|
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000152
C00002645
C00002743
C00004565
|
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001015
C00004565
C00005374
|
| 7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00000152
C00001015
C00002743
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001015
C00004565
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002743
C00004565
|
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002503
C00004565
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002503
C00002743
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002645
C00004565
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002743
C00004565
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002743
C00004565
|
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002743
C00004565
|
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002743
C00004565
|
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002743
C00004565
|
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002743
C00004565
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002645
C00004565
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002645
C00004565
|
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000152
C00002503
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002503
C00004565
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002503
C00004565
|
| 7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00004565
|
| 472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00004565
|
| 239 | ALOX12, 12-LOX, 12S-LOX, LOG12 | arachidonate 12-lipoxygenase (EC:1.13.11.31) |
C00004565
|
| 27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00004565
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00004565
|
| 598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00004565
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00004565
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00004565
|
| 6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00004565
|
| 891 | CCNB1, CCNB | cyclin B1 |
C00004565
|
| 983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00004565
|
| 1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00004565
|
| 1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00004565
|
| 1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00004565
|
| 1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00004565
|
| 1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00004565
|
| 37618 |
C00004565
|
||
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00004565
|
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00004565
|
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00004565
|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00004565
|
| 1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004565
|
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00004565
|
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00004565
|
| 2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00004565
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00004565
|
| 4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00004565
|
| 2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00004565
|
| 9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00004565
|
| 2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00004565
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00004565
|
| 3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00004565
|
| 3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00004565
|
| 3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00004565
|
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00004565
|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00004565
|
| 3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00004565
|
| 3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004565
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00004565
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00004565
|
| 4297 | KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TET1-MLL, TRX1, WDSTS | lysine (K)-specific methyltransferase 2A (EC:2.1.1.43) |
C00004565
|
| 4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00004565
|
| 110357 |
C00004565
|
||
| 4502 | MT2A, MT2 | metallothionein 2A |
C00004565
|
| 4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00004565
|
| 8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00004565
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00004565
|
| 4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00004565
|
| 6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) |
C00002743
|
| 8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00004565
|
| 9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00004565
|
| 5241 | PGR, NR3C3, PR | progesterone receptor |
C00004565
|
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00004565
|
| 8000 | PSCA, PRO232 | prostate stem cell antigen |
C00004565
|
| 6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00004565
|
| 2810 | SFN, YWHAS | stratifin |
C00004565
|
| 6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00004565
|
| 6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00004565
|
| 405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00004565
|
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004565
|
| 7039 | TGFA, TFGA | transforming growth factor, alpha |
C00004565
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002743
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00004565
|
| 9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00004565
|
| 8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00004565
|
| 7161 | TP73, P73 | tumor protein p73 |
C00004565
|
| 7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00004565
|
| 54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00004565
|
| 5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002743
|
| 7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00004565
|
| 8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00004565
|
| 1638 | DCT, TRP-2, TYRP2 | dopachrome tautomerase (EC:5.3.3.12) |
C00001015
|
| 8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00002503
|
| 8574 | AKR7A2, AFAR, AFAR1, AFB1-AR1, AKR7 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11) |
C00002503
|
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002503
|
| 23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) |
C00002743
|
| 7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00002503
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000152
|
| 213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00002645
|
| 6376 | CX3CL1, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin | chemokine (C-X3-C motif) ligand 1 |
C00002645
|
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00002645
|
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00002645
|
| 50848 | F11R, CD321, JAM, JAM1, JAMA, JCAM, KAT, PAM-1 | F11 receptor |
C00002645
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00002645
|
| 10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 |
C00023774
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #613954 | Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia; als14 |
P55072
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #218030 | Apparent mineralocorticoid excess; ame |
P80365
|
| #613546 | Aromatase deficiency |
P11511
|
| #139300 | Aromatase excess syndrome; aexs |
P11511
|
| #600807 | Asthma, susceptibility to |
Q13093
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
| #614490 | Blood group, junior system; jr |
Q9UNQ0
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| %606641 | Body mass index; bmi |
P37231
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P84022
Q14191 |
| #604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
| #218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
| #606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
| #162800 | Cyclic neutropenia |
P08246
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #607208 | Dravet syndrome |
P18507
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
| #612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
| #613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
| #611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #301500 | Fabry disease |
P06280
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613163 | Gaba-transaminase deficiency |
P80404
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
| #604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
| #611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #143500 | Gilbert syndrome |
P22309
P22310 |
| #137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
| #231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
| #137760 | Glaucoma, primary open angle; poag |
Q16678
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #147050 | Ige responsiveness, atopic; iger |
Q13093
|
| #167320 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1; ibmpfd1 |
P55072
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #601626 | Leukemia, acute myeloid; aml |
P36888
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #300635 | Lymphoproliferative syndrome, x-linked, 2; xlp2 |
P98170
|
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #603933 | Microvascular complications of diabetes, susceptibility to, 1; mvcd1 |
P15692
|
| #601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #158580 | Neuronopathy, distal hereditary motor, type viia; hmn7a |
Q9GZV3
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #601665 | Obesity |
P32245
P37231 |
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #604229 | Peters anomaly |
Q16678
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
| #613679 | Prothrombin deficiency, congenital |
P00734
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #265800 | Pycnodysostosis |
P43235
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| %612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
| #601367 | Stroke, ischemic |
P00734
|
| #271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd |
P51649
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
| #277700 | Werner syndrome; wrn |
Q14191
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #278300 | Xanthinuria, type i |
P47989
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P15692 (marker) Q16790 (marker) |
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P15692 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00223 | Inherited thrombophilia |
P00734
(related)
|
| H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) P37231 (related) |
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00125 | Fabry disease |
P06280
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
P55072 (related) |
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00794 | Aromatase excess syndrome |
P11511
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00208 | Hyperbilirubinemia |
P22309
(related)
|
| H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00273 | Pycnodysostosis |
P43235
(related)
|
| H00425 | Lysosomal cysteine protease deficiencies |
P43235
(related)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency |
P51649
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
| H01257 | GABA-transaminase deficiency |
P80404
(related)
|
| H00107 | Other well-defined immunodeficiency syndromes |
P98170
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
| H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
| H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00296 | Defects in RecQ helicases |
Q14191
(related)
|
| H00612 | Primary open angle glaucoma |
Q16678
(related)
|
| H01075 | Peters anomaly |
Q16678
(related)
|
| H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
| H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D050197 | Atherosclerosis |
C00002743
C00004565 |
| D006965 | Hyperplasia |
C00002645
C00003467 |
| D002318 | Cardiovascular Diseases |
C00004565
C00002645 |
| D008545 | Melanoma |
C00002743
C00000152 |
| D007938 | Leukemia |
C00004565
|
| D009203 | Myocardial Infarction |
C00002743
|
| D001943 | Breast Neoplasms |
C00004565
|
| D009202 | Cardiomyopathies |
C00004565
|
| D007249 | Inflammation |
C00002743
|
| D006943 | Hyperglycemia |
C00004565
|
| D008106 | Liver Cirrhosis, Experimental |
C00002743
|
| D010024 | Osteoporosis |
C00004565
|
| D011297 | Prenatal Exposure Delayed Effects |
C00004565
|
| D010146 | Pain |
C00005374
|
| D003873 | Dermatitis, Exfoliative |
C00002645
|
| D002252 | Carbon Tetrachloride Poisoning |
C00002743
|
| D007674 | Kidney Diseases |
C00002645
|
| D056486 | Drug-Induced Liver Injury |
C00003467
|
| D006984 | Hypertrophy |
C00003467
|
| D009336 | Necrosis |
C00003467
|
| D015431 | Weight Loss |
C00003467
|